COVID-19 exposed hospital overload and delays in standard care, highlighting the need for more treatments outside the hospital. Therapies such as sleep apnea care, oxygen therapy, dialysis, and medical nutrition are well suited for home use and show strong potential. However, legal, accreditation, digital, and reimbursement barriers still limit homecare development in Belgium.
De STHA (Services & Technologies Home Assistance) actoren en verleners zijn gekwalificeerde en gespecialiseerde partners die zich ertoe verbinden de technische dienstverlening met medische hulpmiddelen uit te voeren en de opvolging van de therapie van de patiënt te ondersteunen. Zij baseren zich hiervoor op drie pijlers: de patiënt, innovatie en waarde.
The COVID-19 pandemic revealed how quickly hospital capacity can become overwhelmed, delaying standard care. Highly specialized homecare enables treatments such as dialysis and oxygen therapy to continue safely outside hospitals, often improving quality and patient autonomy. Clear regulation, accreditation, digital support, and adequate reimbursement are essential to fully realize homecare’s value in delivering efficient, value-based healthcare.
